Cicada COVID variant BA.3.2 shows new symptoms and rapid spread

The hum of phones buzzing in pockets was a constant reminder of the world in flux. A new COVID-19 variant was at the forefront of everyone's minds. The Cicada variant, officially named BA.3.2, was gaining traction rapidly, with health authorities worldwide on high alert. The Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) were closely monitoring its spread, fearing that its high mutation rate could potentially evade immunity.

Emerging Symptoms of the Cicada Variant

In the fluorescent glare of the briefing room, Dr. Jane Thompson of the CDC stood before a crowd of reporters. She highlighted the unique symptoms of the Cicada variant, which included a sharp sore throat often described as "glass-like" or intense pain, rather than the typical scratchy sensation. The variant also presented with gastrointestinal symptoms, adding a new layer of complexity to diagnosis and treatment. — This was unlike anything they had seen before.

The Spread and Impact

As of February 2026, the Cicada variant had been reported in 23 countries and was steadily rising in cases across the nation. By March, it had spread to at least 25 U.S. states, prompting the CDC to issue a warning about its potential to evade immunity and spread faster than previous variants. The CDC was particularly concerned about the variant's 70 to 75 mutations, which made it highly adaptable and potentially more dangerous.

Public Health Response and Future Concerns

In response to the Cicada variant's emergence, public health officials emphasized the importance of vaccination and continued vigilance. Dr. Thompson warned that while the severity of illness appeared similar to previous variants, the unique symptoms and rapid spread required immediate attention. "We need to be proactive," she insisted, "not reactive." The CDC was working closely with local health departments to track the variant's spread and provide guidelines for managing its symptoms.

"The Cicada variant is a reminder that the COVID-19 pandemic is far from over," Dr. Thompson said. "We must remain vigilant and adapt our strategies to combat this evolving threat."

With the Cicada variant spreading rapidly and presenting unique symptoms, the world is once again on edge. As health authorities race to understand and contain this new threat, one burning question remains: How will the Cicada variant continue to evolve, and what new challenges will it present to global health efforts?